期刊文献+

激光光凝术治疗眼底病临床疗效观察及并发症防治效果 被引量:1

原文传递
导出
摘要 目的:激光光凝术治疗眼底疾病的临床效果。方法:回顾性分析柳州市红十字会医院患有眼底疾病,具有视网膜激光光凝及药物治疗指征的患者80例,其中40例采用常规药物治疗(对照组),40例实施激光光凝术治疗(试验组),比较2组治疗效果。结果:试验组治疗有效率是95.00%,高于对照组的75.00%(P<0.05);试验组不良反应是12.50%,明显低于对照组的32.50%(P<0.05);两组治疗前生活质量无显著差异(P>0.05),治疗1-2个月后试验组生活质量明显高于对照组(P<0.05)。结论:眼底疾病实施激光光凝术治疗效果显著,不仅有效提高患者视力,降低不良症状发生、提高临床治疗效果,还有效提高其生活质量,因此值得临床应用及推广。
作者 谢姣艳
出处 《保健文汇》 2021年第2期87-88,共2页 Health Literature
作者简介 谢姣艳(1990~),女,本科,住院医师,研究方向为眼底。
  • 相关文献

参考文献9

二级参考文献79

  • 1Palmer E A , Phelps D.Multicenter trial of cryothera- py for retinopathy of prematurity.Preliminary results. Cryotherapy for Retinopathy of Prematurity Coopera- tive Group [J].Arch Ophthalmol,2008,106 (4):471- 479.
  • 2Kim JE, Lee AC. Demographic Changes and Re- sponse to Laser Treatment in Threshold Retinopathy of Prematurity: 10-Year Experience [J].J Pediatr Ophthalmol Strabismus 2010,47(4):231-235.
  • 3Axer-Siegel R, Maharshak I, Snir M, et al . Diode laser treatment of retinopathy of prematurity: anatom- ical and refractive outcomes [J].Retina 2008, 28(6): 839-846.
  • 4Talu S. Cormos D. Zaharia G. et al. Prognostic fac- tors for laser treatment in retinopathy of prematurity [J ].Ophthalmologia, 2011,55(1):84-89.
  • 5Gotz-Wieckowska A, Kociecki J, Burchardt-Kroll E, et al. The results of diode treatment of active phase of retinopathy of prematurity [J].KliOczna, 2003, 105(6):395-397. .
  • 6Sanghi G, Dogra MR, Das P, et al . Aggressive posterior retinopathy of prematurity in Asian Indian babies: spectrum of disease and outcome after laser treatment [ J ].Retina 2009,29(9): 1335-1339.
  • 7COLEMAN AL. Advances in glaucoma treatment and manage- ment: surgery [J]. Invest Ophthalmol Vis Sci, 2012,53 ( 5 ) : 2491-2494.
  • 8COSTAGLIOLA C, CIPOLLONE U, RINALDI M, DELLA- CORTE M, SEMERARO F, ROMANO MR. Intravitreal bevaci- zumab( Avastin? ) injection for neovascular glaucoma: a sur- vey on 23 cases throughout 12-month follow-up [ J ]. Br J Clin Pharmacol,2008,66( 5 ) :667-673.
  • 9YAZDANI S, HENDI K, PAKRAVAN M, MAHDAVI M, YASERI M. Intravitreal bevacizumab for neovascular glaucoma:a ran- domized controlled trial [ J]. J Glaucoma, 2009,18 (8) :632- 637.
  • 10SEVIM MS, BUTTANRI IB, KUGU S, SERIN D, SEVIM S. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma [ J ]. Ophthalmologica, 2013,229 ( 2 ) : 94-100.

共引文献61

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部